These findings encouraged us to test whether the observed therapeutic effect of weekly administration of GA in APP/PS1 mice33 could be reproduced in 5XFAD AD-Tg mice, and if so, whether it would involve an effect on systemic Tregs and IFN-γ-activation of the CP for mo-MΦ trafficking. This evidence concerns the gene CP and Alzheimer disease.